Drug Database
L04AD02 tacrolimus
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Adoport 0.5 mg Capsules, hard
- POM Adoport 0.75 mg Capsules, hard
- POM Adoport 1 mg Capsules, hard
- POM Adoport 2 mg Capsules, hard
- POM Adoport 5 mg Capsules, hard
- POM Advagraf 0.5mg, 1mg, 3mg and 5mg Prolonged-release hard capsules (Great Britain)
- POM Dailiport 0.5 mg prolonged-release hard capsules
- POM Dailiport 1 mg prolonged-release hard capsules
- POM Dailiport 2 mg prolonged-release hard capsules
- POM Dailiport 3 mg prolonged-release hard capsules
- POM Dailiport 5 mg prolonged-release hard capsules
- POM Envarsus 0.75mg, 1mg & 4mg prolonged-release tablets
- POM Modigraf 0.2mg & 1mg granules for oral suspension (Great Britain)
- POM Prograf 0.5mg, 1mg, 5mg Hard Capsules (UK)
- POM Prograf 5mg/ml Concentrate for Solution for Infusion (UK)
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).